Stock Ratings | BTIG initiated coverage on Perspective Therapeutics (CATX) with a "Buy" rating and a $14 price target, indicating a potential upside of 188.07%.
Sahm Platform 13/10 13:10
'ByteDance Is Developing AI Smart Glasses' - The Information
Meta Platforms META | 0.00 | |
Oracle Corporation ORCL | 0.00 | |
Snap SNAP | 0.00 |
https://www.theinformation.com/articles/bytedance-developing-ai-smart-glasses